GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » 5-Year Yield-on-Cost %

Shire (SHPG) 5-Year Yield-on-Cost % : 0.59 (As of Apr. 26, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Shire 5-Year Yield-on-Cost %?

Shire's yield on cost for the quarter that ended in Sep. 2018 was 0.59.


The historical rank and industry rank for Shire's 5-Year Yield-on-Cost % or its related term are showing as below:

SHPG' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.59
Current: 0.59


During the past 13 years, Shire's highest Yield on Cost was 0.59. The lowest was 0.00. And the median was 0.00.


SHPG's 5-Year Yield-on-Cost % is not ranked
in the Biotechnology industry.
Industry Median: 1.975 vs SHPG: 0.59

Competitive Comparison of Shire's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Shire's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shire's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shire's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Shire's 5-Year Yield-on-Cost % falls into.



Shire 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Shire is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Shire  (NAS:SHPG) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Shire 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Shire's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shire (SHPG) Business Description

Traded in Other Exchanges
N/A
Address
Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.
Executives
James H Cavanaugh director 265 HOTHORPE LANE, VILLANOVA PA 19085

Shire (SHPG) Headlines

From GuruFocus